In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosis Strains

Current therapy for pulmonary tuberculosis involves 6 months of treatment with isoniazid, pyrazinamide, rifampin, and ethambutol or streptomycin for reliable treatment efficacy. The long treatment period increases the probability of noncompliance, leading to the generation of multidrug-resistant iso...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Oleksijew, Andy, Meulbroek, Jon, Ewing, Patty, Jarvis, Ken, Mitten, Mike, Paige, Lenette, Tovcimak, Ann, Nukkula, Mike, Chu, Daniel, Alder, Jeffrey D.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105917/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756775/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2674
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!